SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,680,778 | +6.1% | 360,343 | +0.3% | 0.13% | +4.9% |
| Q2 2023 | $41,154,938 | +516.2% | 359,369 | +641.6% | 0.12% | +481.0% |
| Q1 2023 | $6,678,690 | -92.7% | 48,456 | -93.1% | 0.02% | -93.2% |
| Q4 2022 | $91,192,573 | -3.2% | 703,755 | -17.4% | 0.31% | -17.6% |
| Q3 2022 | $94,169,000 | +195.2% | 851,900 | +100.2% | 0.38% | +178.5% |
| Q2 2022 | $31,896,000 | -71.8% | 425,507 | -70.6% | 0.14% | -69.9% |
| Q1 2022 | $113,056,000 | +7.5% | 1,447,211 | +23.9% | 0.45% | +6.9% |
| Q4 2021 | $105,152,000 | -38.4% | 1,167,709 | -36.7% | 0.42% | -44.0% |
| Q3 2021 | $170,718,000 | +424.6% | 1,846,000 | +341.0% | 0.75% | +413.7% |
| Q2 2021 | $32,542,000 | +214.1% | 418,600 | +201.2% | 0.15% | +204.2% |
| Q1 2021 | $10,359,000 | -76.7% | 138,986 | -59.7% | 0.05% | -79.5% |
| Q4 2019 | $44,481,000 | -15.2% | 344,710 | -50.5% | 0.23% | -27.3% |
| Q3 2019 | $52,474,000 | -4.5% | 696,685 | +51.2% | 0.32% | +29.3% |
| Q1 2019 | $54,922,000 | +546.1% | 460,790 | +491.6% | 0.25% | +492.9% |
| Q4 2018 | $8,500,000 | -20.0% | 77,893 | +18.4% | 0.04% | -4.5% |
| Q3 2018 | $10,623,000 | -72.4% | 65,770 | -77.4% | 0.04% | -71.2% |
| Q2 2018 | $38,433,000 | +245.8% | 290,761 | +93.8% | 0.15% | +232.6% |
| Q1 2018 | $11,114,000 | -74.4% | 150,000 | -80.8% | 0.05% | -75.4% |
| Q4 2017 | $43,386,000 | -41.9% | 779,757 | -52.6% | 0.19% | -43.8% |
| Q3 2017 | $74,630,000 | +9.3% | 1,645,275 | -18.8% | 0.33% | -13.1% |
| Q2 2017 | $68,276,000 | +187.1% | 2,025,406 | +152.1% | 0.38% | +188.0% |
| Q1 2017 | $23,778,000 | -40.9% | 803,300 | -45.3% | 0.13% | -52.7% |
| Q4 2016 | $40,256,000 | -81.5% | 1,467,599 | -58.5% | 0.28% | -81.6% |
| Q3 2016 | $217,041,000 | +192.0% | 3,534,287 | -9.3% | 1.53% | +201.6% |
| Q2 2016 | $74,328,000 | +28.5% | 3,897,600 | +31.6% | 0.51% | +14.0% |
| Q1 2016 | $57,823,000 | -45.6% | 2,962,231 | +7.5% | 0.44% | -49.4% |
| Q4 2015 | $106,323,000 | +263.7% | 2,755,900 | +202.7% | 0.88% | +283.0% |
| Q3 2015 | $29,232,000 | -13.6% | 910,370 | -18.1% | 0.23% | -2.1% |
| Q2 2015 | $33,823,000 | +35.7% | 1,111,500 | -40.8% | 0.23% | +37.6% |
| Q1 2015 | $24,928,000 | -5.7% | 1,877,100 | +2.8% | 0.17% | -8.6% |
| Q4 2014 | $26,429,000 | +36.4% | 1,826,500 | +98.9% | 0.19% | +27.4% |
| Q3 2014 | $19,380,000 | +139.1% | 918,500 | +237.6% | 0.15% | +180.8% |
| Q2 2014 | $8,106,000 | – | 272,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |